Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)

Historical Holders from Q4 2020 to Q3 2025

Symbol
AVIR on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
78,411,033
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
53,140,827
Holdings value
$154,099,214
% of all portfolios
0.003%
Number of holders
111
Number of buys
43
Number of sells
-45
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 11.6% +70% $29,470,003 +$10,937,987 9,095,679 +59% FMR LLC 28 Nov 2025
Sommadossi Jean-Pierre 10.1% $26,185,536 8,876,453 Jean-Pierre Sommadossi 31 Mar 2025
BML Investment Partners, L.P. 8.5% $21,288,120 7,216,312 Leonard Braden Michael 13 Dec 2024
BlackRock, Inc. 7.1% $17,942,932 6,082,350 BlackRock, Inc. 31 Mar 2025
Radoff Bradley Louis 4% +10% $9,971,295 +$811,250 3,380,100 +8.9% Radoff Bradley Louis 16 Apr 2025
EcoR1 Capital, LLC 4% $9,857,876 3,341,653 EcoR1 Capital, LLC 31 Dec 2024

Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 53,140,827 $154,099,214 +$874,811 $2.9 111
2025 Q2 52,688,325 $189,687,193 -$496,611 $3.6 105
2025 Q1 52,943,893 $158,295,789 -$11,408,006 $2.99 102
2024 Q4 56,328,149 $188,651,399 -$6,772,701 $3.35 103
2024 Q3 57,907,511 $193,998,567 +$4,533,749 $3.35 105
2024 Q2 56,687,549 $187,637,646 +$7,123,002 $3.31 101
2024 Q1 54,332,807 $219,504,800 -$1,664,806 $4.04 112
2023 Q4 55,088,379 $168,248,591 -$1,691,841 $3.05 106
2023 Q3 56,849,245 $170,555,234 -$2,209,314 $3 117
2023 Q2 57,041,241 $213,289,848 +$971,494 $3.74 131
2023 Q1 56,778,720 $190,176,002 -$5,878,803 $3.35 128
2022 Q4 57,878,556 $278,395,526 -$5,016,357 $4.81 130
2022 Q3 57,466,718 $326,999,436 -$1,731,457 $5.69 115
2022 Q2 57,566,762 $408,727,109 +$19,469,875 $7.1 122
2022 Q1 54,946,542 $396,539,427 +$6,369,699 $7.22 121
2021 Q4 53,581,427 $478,985,081 -$368,375,568 $8.94 134
2021 Q3 56,840,788 $1,992,582,650 -$21,707,203 $35.06 137
2021 Q2 58,896,806 $1,265,508,812 +$160,923,836 $21.48 100
2021 Q1 47,389,412 $2,914,493,173 +$30,510,569 $61.75 78
2020 Q4 49,910,976 $2,070,766,859 +$1,819,869,860 $41.78 69